Tang Xin, Lin Ying, Liu Bing, Ma Shi, Yang Yang, Yang Zheng-lin
Sichuan Provincial Key Laboratory for Human Disease Gene, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, Chengdu, Sichuan, 610072, PR China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Oct;26(5):499-503. doi: 10.3760/cma.j.issn.1003-9406.2009.05.004.
To perform linkage analysis and mutation screening in a Chinese family with familial hpertriglyceridemia (FHTG).
Thirty-two family members including 12 hypertriglyceridemia patients participated in the study. Genotyping and haplotype analysis for 22 subjects were performed using short tandem repeat (STR) microsatellite polymorphism markers on 16 candidate genes and/or loci related to lipid metabolism. Two of the sixteen known candidate genes, APOA2 and USF1 were screened for mutation by direct DNA sequencing.
No linkage was found between the candidate genes/loci of APOA5, LIPI, RP1, APOC2, ABC1, LMF1, APOA1-APOC3-APOA4, LPL, APOB, CETP, LCAT, LDLR, APOE and the phenotype in this family. The two-point Lod scores (theta =0) were all less than-1.0 for all the markers tested. Linkage analysis suggested linkage to chromosome 1q23.3-24.2 between the disease phenotype and STR marker D1S194 with a two-point maximum Lod score of 2.44 at theta =0. Fine mapping indicated that the disease gene was localized to a 5.87 cM interval between D1S104 and D1S196. No disease-causing mutation was detected in the APOA2 and USF1 genes.
The above mentioned candidate genes were excluded as the disease causing genes for this family. The results implied that there might be a novel gene/locus for FHTG on chromosome 1q23.3-1q24.2.
对一个中国家族性高甘油三酯血症(FHTG)家系进行连锁分析和突变筛查。
32名家族成员包括12名高甘油三酯血症患者参与了研究。使用短串联重复(STR)微卫星多态性标记对16个与脂质代谢相关的候选基因和/或位点,对22名受试者进行基因分型和单倍型分析。通过直接DNA测序对16个已知候选基因中的两个,即载脂蛋白A2(APOA2)和上游刺激因子1(USF1)进行突变筛查。
在该家系中,载脂蛋白A5(APOA5)、脂肪酶(LIPI)、视网膜色素变性1(RP1)、载脂蛋白C2(APOC2)、ATP结合盒转运体A1(ABC1)、脂酶成熟因子1(LMF1)、载脂蛋白A1-载脂蛋白C3-载脂蛋白A4(APOA1-APOC3-APOA4)、脂蛋白脂肪酶(LPL)、载脂蛋白B(APOB)、胆固醇酯转运蛋白(CETP)、卵磷脂胆固醇酰基转移酶(LCAT)、低密度脂蛋白受体(LDLR)、载脂蛋白E(APOE)的候选基因/位点与表型之间未发现连锁关系。所有检测标记的两点Lod分数(θ = 0)均小于-1.0。连锁分析提示疾病表型与STR标记D1S194之间在染色体1q23.3-24.2存在连锁,两点最大Lod分数在θ = 0时为2.44。精细定位表明致病基因定位于D1S104和D1S196之间5.87 cM的区间内。在APOA2和USF1基因中未检测到致病突变。
上述候选基因被排除为该家系的致病基因。结果提示在染色体1q23.3-1q24.2上可能存在一个新的FHTG基因/位点。